Navigation Links
Live Press Briefing on Findings of Biomedical Industry CEO Survey
Date:1/9/2012

SAN FRANCISCO, Jan. 9, 2012 EVENT:Live Press Briefing on Findings of Biomedical Industry CEO SurveyWHEN:Tuesday, Jan. 10, 2012 TIME:10 a.m. – 10:45 a.m. PT presentation and Q&A 

 WHO:-- CEOs from three biotechnology companies: NuVasive (NASDAQ: NUVA), Omniox and Theravance (NASDAQ: THRX) 

-- Executives from BayBio, California Healthcare Institute and PwC USWHERE:Grand Hyatt San Francisco 

Conference Theatre 

345 Stockton St. 

San Francisco, CA 94108  

To listen by phone in the United States: (800) 230-1951 (Logo: http://photos.prnewswire.com/prnh/20100917/NY66894LOGO )

Findings of a new survey of biomedical company CEOs about the future of the biomedical industry will be unveiled at a live press briefing hosted by the California Healthcare Institute, BayBio and PwC in San Francisco on Tuesday, Jan. 10. Some of the questions that will be addressed during the briefing include:

  • What are the biggest threats to future growth of the biomedical industry?
  • How are biomedical companies adapting to new threats and opportunities?
  • Where are biomedical companies turning for capital, and who will finance new innovation in the future?
  • How does the relationship between industry and FDA help or hinder innovation?
  • What are the key state and federal policy issues that will influence the ability for the United States and California to maintain global leadership in biomedical innovation?
  • While the biomedical industry may be poised for explosive growth over the next five to 10 years, the pace will be determined by a confluence of factors — the political, economic and regulatory environment, the availability of capital, health reform, globalization and state and federal budget deficits. These factors and the relative risks and opportunities they represent to the biomedical industry are among the topics explored by the survey.

    The briefing will include a presentation of research highlights, followed by a candid discussion among the CEOs of three California-based biomedical companies. The briefing will allow time at the conclusion for questions from the audience and members of the media.

  • NuVasive, Alexis Lukianov, Chairman and CEO
  • Omniox, Stephen Cary, Ph.D., CEO and Co-Founder
  • Theravance, Rick Winningham, Chairman and CEO
  • BayBio, Gail Maderis, President and CEO
  • California Healthcare Institute, David Gollaher, Ph.D., President and CEO
  • PwC, Tracy Lefteroff, National Life Sciences Partner
  • About the California Healthcare Institute
    CHI represents more than 275 leading biotechnology, medical device, diagnostics, and pharmaceutical companies, and public and private academic biomedical research organizations. CHI's mission is to advance responsible public policies that foster medical innovation and promote scientific discovery. CHI's website is www.chi.org. Follow us on Twitter @calhealthcare, Facebook, LinkedIn and YouTube.

    About BayBio
    BayBio is Northern California's life science association, supporting the regional bioscience community through advocacy, enterprise support, and the enhancement of research collaboration. Its members include organizations engaged in, or supportive of, research, development and commercialization of life science technologies. Online at www.baybio.org.Follow BayBio on Twitter at @baybio

    About the PwC Network
    PwC firms help organizations and individuals create the value they're looking for. We're a network of firms in 158 countries with close to 169,000 people who are committed to delivering quality in assurance, tax and advisory services. Tell us what matters to you and find out more by visiting us at www.pwc.com.
    © 2011 PricewaterhouseCoopers LLP, a Delaware limited liability partnership. All rights reserved. PwC refers to the US member firm, and may sometimes refer to the PwC network. Each member firm is a separate legal entity. Please see www.pwc.com/structure for further details.

     

     

     


    '/>"/>
    SOURCE PwC
    Copyright©2010 PR Newswire.
    All rights reserved

    Related biology technology :

    1. Veracyte Announces Medicare Coverage for Its Afirma® Gene Expression Classifier for Improved Thyroid Nodule Diagnosis
    2. Generex Subsidiary Antigen Express Provides Update on AE37 Cancer Vaccines Clinical & Regulatory Strategy
    3. Breast Cancer Vaccine Being Developed by Generex Subsidiary Antigen Express to be Featured on Bloomberg Television Today
    4. Compressus Drives Programmable Workflow And Unprecedented Flexibility With Introduction of MEDxConnect™ v4.0
    5. Nations Best Health Care Organizations for Patient Satisfaction, Core Measures Honored by Press Ganey
    6. Bright Light into the Ear Canal Treats Seasonal Depression Effectively in Two Clinical Trials Presented by Valkee and University of Oulu
    7. Epitomics, Inc. Receives Notice of Allowance from the United States Patent and Trademark Office for a Novel Method for Identifying Differentially Expressed Proteins
    8. Drug-Free BLOOD PRESSURE Control & Medical "Take-Away" Treatment are Potential Win-Win Solutions in Health Care
    9. Optics Express Focus Issue: Collective phenomena in photonic, plasmonic and hybrid structures
    10. ReportsnReports: Depression Therapeutics Market to Reach $10.9 Billion by 2018
    11. Nexcelom Bioscience to Distribute FCS Express 4 Cytometry Software with Cellometer Vision CBA Instruments
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/25/2016)... ... May 25, 2016 , ... The American Medical ... Office of the National Coordinator for Health IT (ONC) outlining a measurement approach ... data were available when and where it was needed. The organization of health ...
    (Date:5/25/2016)... , ... May 25, 2016 , ... WEDI, the nation’s ... exchange, today announced that Charles W. Stellar has been named by the WEDI Board ... since January 2016. As an executive leader with more than 35 years of experience ...
    (Date:5/25/2016)... Connecticut (PRWEB) , ... May 25, 2016 , ... ... the U.S. Food and Drug Administration (FDA) has granted the company’s orphan drug ... the company’s second orphan drug designation granted by the FDA. , Spinocerebellar ...
    (Date:5/24/2016)... TEL AVIV, Israel , May 24, 2016   ... on providing physicians with artificial intelligence, real-time decision support tools ... selected to present at the 2016 Israeli Advanced Technology Industries ... part of Israel,s 15th National Life ... to 26th at the David Intercontinental Hotel in ...
    Breaking Biology Technology:
    (Date:5/16/2016)... YORK , May 16, 2016   EyeLock ... solutions, today announced the opening of an IoT Center ... to strengthen and expand the development of embedded iris ... an unprecedented level of convenience and security with unmatched ... authenticate one,s identity aside from DNA. EyeLock,s platform uses ...
    (Date:4/28/2016)... BANGALORE, India , April 28, 2016 ... subsidiary of Infosys (NYSE: INFY ), and Samsung ... global partnership that will provide end customers with a ... and payment services.      (Logo: http://photos.prnewswire.com/prnh/20130122/589162 ... for financial services, but it also plays a fundamental part ...
    (Date:4/19/2016)... -- The new GEZE SecuLogic access control ... system solution for all door components. It can be ... interface with integration authorization management system, and thus fulfills ... dimensions of the access control and the optimum integration ... considerable freedom of design with regard to the doors. ...
    Breaking Biology News(10 mins):